Repare Therapeutics Inc. ( RPTX) - Key Metrics
Stock symbol RPTX is outdated, potentially delisted? Maybe it is available on other exchange?
RPTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | ? | $0.08 | $0.06 | $0.06 |
| 2025Q2 | $0.01 | -$0.39 | -$0.38 | -$0.38 |
| 2025Q1 | ? | -$0.71 | -$0.68 | -$0.68 |
| 2024Q4 | -$1.26 | -$0.68 | -$0.64 | -$0.64 |
| 2024Q3 | $1.26 | -$0.81 | -$0.72 | -$0.72 |
RPTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | 5.80 |
| 2025Q2 | ? | -0.89 |
| 2025Q1 | ? | -0.35 |
| 2024Q4 | ? | -0.48 |
| 2024Q3 | ? | -1.06 |
RPTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 3.51% | ? |
| 2025Q2 | -27.39% | ? |
| 2025Q1 | -69.38% | ? |
| 2024Q4 | -49.18% | ? |
| 2024Q3 | -20.91% | ? |
RPTX
Price: $2.65
52 week price:
Earnings Per Share: -1.70 USD
P/E Ratio: -1.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 108000
Market Capitalization: 110.5 million